Zivo Bioscience Inc. (ZIVO)
| Market Cap | 39.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.78M |
| Shares Out | 9.06M |
| EPS (ttm) | -1.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 18 |
| Last Price | $4.38 |
| Previous Close | $4.51 |
| Change ($) | -0.13 |
| Change (%) | -2.88% |
| Day's Open | 4.48 |
| Day's Range | 4.31 - 4.48 |
| Day's Volume | 138,355 |
| 52-Week Range | 3.75 - 7.20 |
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nu...
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical prod...
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical pr...
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and additive pro...
KEEGO HARBOR, MI / ACCESSWIRE / January 11, 2021 / ZIVO Bioscience, Inc. (OTCQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic/additive product candid...
KEEGO HARBOR, MI / ACCESSWIRE / January 7, 2021 / ZIVO Bioscience, Inc. (OTCMQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, food and feed additive...
About ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal h... [Read more...]
| Industry Biotechnology | |
| Stock Exchange NASDAQ | Ticker Symbol ZIVO |